Ποια είναι η τιμή για Evogene Ltd. (EVGN)

Η τιμή για Evogene Ltd. (EVGN) είναι $0.6110603

Ποια είναι η κεφαλαιοποίηση αγοράς για Evogene Ltd. (EVGN)

Η κεφαλαιοποίηση αγοράς για Evogene Ltd. (EVGN) είναι $52.65K

Evogene Ltd. (EVGN) Τιμή και Κεφαλαιοποίηση Αγοράς

Evogene Ltd. is a computational biology firm specializing in the identification and advancement of products across human health and agricultural sectors. Its proprietary Computational Predictive Biology (CPB) platform leverages deep biological insights, big data, and artificial intelligence to precisely uncover and guide the creation of life science solutions, including novel microbes, small molecules, and genetic components. The company operates through distinct divisions: Agriculture, Human Health, and Industrial Applications. The Agriculture division concentrates on improving crop performance through the development of advanced seed traits, agricultural chemicals, and biological products for crops like corn, soybean, wheat, rice, and cotton. The Human Health division focuses on pioneering microbiome-based treatments for conditions such as immuno-oncology, gastrointestinal ailments, and antibiotic-resistant infections, and also offers medical cannabis products. The Industrial Applications segment is dedicated to developing improved castor bean varieties for various industrial feedstock requirements. Evogene has a global footprint, conducting business in the United States, Israel, Brazil, and other international markets. It maintains significant partnerships, including agricultural collaborations with BASF SE, Corteva, and Bayer, and a medical cannabis development agreement with Cannbit Ltd. through its subsidiary, Canonic Ltd. Established in 1999, Evogene Ltd. is headquartered in Rehovot, Israel.

Η τιμή για EVGN	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$62,475,159 $52.65K	NVDA	$5.383T	+10,224,057,775.96%
$51,334,500 $52.65K	AAPL	$4.423T	+8,400,889,346.65%
$48,282,070 $52.65K	GOOG	$4.160T	+7,901,359,234.75%
$42,513,704 $52.65K	MSFT	$3.663T	+6,957,366,305.49%
$33,553,393 $52.65K	AMZN	$2.891T	+5,491,011,740.55%

Η τιμή για EVGN

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$62,475,159 $52.65K